CompanyGraphAt a glance
- Depends onDownstream position: depends on 12 industries, supplies 7
- ScaleRevenue is $4.81M, lower than 95% of all stocks globally
- Interpretations7 currently firing — 7
Sign in to view price data.
Sign inThe reported statements, read against the company's own industry.
As of FY2025 (year ended March 31, 2025). Newer annual figures aren't yet on file.
Financials view
Market Capitalization
504.26MUSDvs all stocks (USD)
Revenue (TTM)
4.81MUSDvs all stocks (USD)
Profit Margin
-0.47%vs Medical Care Facilities peers
52-Week Change
319.36%vs all stocks
Market Capitalization
504.26MUSDvs all stocks (USD)
Enterprise Value
497.49MUSDvs all stocks (USD)
Price to Book (MRQ)
97.20xvs Medical Care Facilities peers
Enterprise to Revenue
103.48xvs Medical Care Facilities peers
Profit Margin
-0.47%vs Medical Care Facilities peers
Operating Margin
4.86%vs Medical Care Facilities peers
Return on Assets (TTM)
0.89%vs Medical Care Facilities peers
Return on Equity (TTM)
-0.87%vs Medical Care Facilities peers
Revenue (TTM)
4.81MUSDvs all stocks (USD)
Revenue per Share (TTM)
0.2980USDUpdated Sep 28, 2026Quarterly Revenue Growth
-18.90%vs Medical Care Facilities peers
Gross Profit (TTM)
4.63MUSDvs all stocks (USD)
EBITDA (TTM)
330.62KUSDvs all stocks (USD)
Net Income (TTM)
-22.65KUSDvs all stocks (USD)
Quarterly Earnings Growth (YoY)
-93.10%vs Medical Care Facilities peers
Operating Cash Flow (TTM)
-1.22MUSDvs all stocks (USD)
Levered Free Cash Flow (TTM)
-507.04KUSDvs all stocks (USD)
Trailing Annual Dividend Rate
0.00USDUpdated Sep 28, 2026Trailing Annual Dividend Yield
0.00%vs all stocks
Payout Ratio
0.00%vs Medical Care Facilities peers
Minority Interest (Equity)
0.00USDFY2025 · Mar 31, 2025Revenue
6.22MUSDFY2025 · Mar 31, 2025Cost of Goods Sold
2.04MUSDFY2025 · Mar 31, 2025Gross Profit
4.18MUSDFY2025 · Mar 31, 2025Operating Income
1.62MUSDvs all stocks (USD)
Pre-tax Income
1.44MUSDFY2025 · Mar 31, 2025Income Tax Expense
236.08KUSDFY2025 · Mar 31, 2025Net Income
1.20MUSDFY2025 · Mar 31, 2025EBIT
1.46MUSDFY2025 · Mar 31, 2025EBITDA (Income Statement)
1.72MUSDFY2025 · Mar 31, 2025Selling, General & Administrative
2.32MUSDFY2025 · Mar 31, 2025Other Operating Expenses
-15.49KUSDFY2025 · Mar 31, 2025Non-operating Interest Income
64.14KUSDFY2025 · Mar 31, 2025Non-operating Interest Expense
20.87KUSDFY2025 · Mar 31, 2025Net Income from Continuing Operations
1.20MUSDFY2025 · Mar 31, 2025Minority Interests (P&L)
0.00USDFY2025 · Mar 31, 2025Operating Cash Flow
284.35KUSDFY2025 · Mar 31, 2025Free Cash Flow
-3.18KUSDFY2025 · Mar 31, 2025Cash & Cash Equivalents (End of Period)
816.77KUSDFY2025 · Mar 31, 2025Interest Paid
20.87KUSDFY2025 · Mar 31, 2025Starting Profit (CF Statement)
1.20MUSDFY2025 · Mar 31, 2025Depreciation & Amortization
263.45KUSDFY2025 · Mar 31, 2025Deferred Taxes (CF)
134.87KUSDFY2025 · Mar 31, 2025Other Non-cash Items
-8.27KUSDFY2025 · Mar 31, 2025Change in Accounts Receivable (CF)
-44.29KUSDFY2025 · Mar 31, 2025Change in Accounts Payable (CF)
-204.69KUSDFY2025 · Mar 31, 2025Change in Other Assets/Liabilities
-1.06MUSDFY2025 · Mar 31, 2025Capital Expenditures
-287.53KUSDFY2025 · Mar 31, 2025Purchase of Investments
-1.94MUSDFY2025 · Mar 31, 2025Net Investing Cash Flow
-2.23MUSDFY2025 · Mar 31, 2025Long-term Debt Issuance
205.87KUSDFY2025 · Mar 31, 2025Long-term Debt Payments
-156.94KUSDFY2025 · Mar 31, 2025Net Short-term Debt Issuance
-130.78KUSDFY2025 · Mar 31, 2025Other Financing Charges
472.37KUSDFY2025 · Mar 31, 2025Net Financing Cash Flow
390.52KUSDFY2025 · Mar 31, 2025Shares Outstanding
15.18MSharesUpdated Sep 28, 2026Float Shares
4.83MSharesUpdated Sep 28, 2026Shares Short
574.77KSharesUpdated Sep 28, 2026Short % of Shares Outstanding
11.91%vs all stocks
% Held by Insiders
68.19%vs all stocks
% Held by Institutions
0.27%vs all stocks
Total Cash (MRQ)
7.68MUSDvs all stocks (USD)
Total Cash per Share (MRQ)
0.4470USDUpdated Sep 28, 2026Total Debt (MRQ)
908.02KUSDvs all stocks (USD)
Current Ratio (MRQ)
1.89xvs Medical Care Facilities peers
Book Value per Share (MRQ)
0.3020USDUpdated Sep 28, 2026Total Assets
5.36MUSDvs all stocks (USD)
Total Current Assets
3.37MUSDFY2025 · Mar 31, 2025Total Liabilities
5.31MUSDFY2025 · Mar 31, 2025Total Non-current Assets
1.99MUSDFY2025 · Mar 31, 2025Total Non-current Liabilities
358.03KUSDFY2025 · Mar 31, 2025Total Current Liabilities
4.95MUSDFY2025 · Mar 31, 2025Cash & Cash Equivalents
816.77KUSDFY2025 · Mar 31, 2025Other Short-term Investments
1.94MUSDFY2025 · Mar 31, 2025Accounts Receivable
395.90KUSDFY2025 · Mar 31, 2025Inventory
26.80KUSDFY2025 · Mar 31, 2025Accounts Payable
3.48KUSDFY2025 · Mar 31, 2025Short-term Debt
802.61KUSDFY2025 · Mar 31, 2025Deferred Revenue
3.46MUSDFY2025 · Mar 31, 2025Long-term Debt
358.03KUSDFY2025 · Mar 31, 2025Common Stock (Book)
1.53KUSDFY2025 · Mar 31, 2025Retained Earnings
119.44KUSDFY2025 · Mar 31, 2025Total Shareholders' Equity
49.24KUSDvs all stocks (USD)
52-Week Low
4.30USDUpdated Sep 28, 202652-Week High
31.70USDUpdated Sep 28, 202652-Week Change
319.36%vs all stocks
50-Day MA
29.36USDUpdated Sep 28, 2026200-Day MA
29.36USDUpdated Sep 28, 2026Avg 10-Day Volume
425.14KSharesUpdated Sep 28, 2026Avg 30-Day Volume
147.51KSharesUpdated Sep 28, 2026Diluted EPS (TTM)
0.0700USDUpdated Sep 28, 2026Other Income / Expense
-12.52KUSDFY2025 · Mar 31, 20257 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsHow does this company use capital?
Diagnostic
Elevated ROE With High Debt-to-Equity and Equity Multiplier
Return on equity reads high on a balance sheet carrying a lot of debt against that equity.
Reads
Diagnostic
Depreciation-Heavy Reported Profit
It reports a profit, and much of the gap to cash is depreciation rather than earnings.
Reads
Diagnostic
Earnings Growth With Heavy Accrual Component
It reports a profit, with depreciation heavy in the cash bridge and receivables rising.
Reads
Working Capital Pattern
What customers owe has grown three years running, while it clears stock quickly and pays suppliers quickly.
Reads
Operating Income Growing With Multi-Year Revenue Growth
Revenue up in each of five years, with operating income up in each of four.
Reads
ROE, ROA, And Operating ROA Elevated
It earns more on its equity than its industry does, and on its assets too — not on borrowing alone.
Reads
Three Turnover Ratios Elevated
Collects fast, clears inventory fast, and pays suppliers fast too.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Supply Chain
Downstream position: depends on 12 industries, supplies 7Notable
Outgoing: 7.00Incoming: 12.00
High connectivity hub: 19 industry connectionsNotable
Total Connections: 19.00
Scale
Revenue is $4.81M, lower than 95% of all stocks globallySignificant
Revenue (USD): 4,807,713Global P5: 33,357,653.812
Companies that share the same coordination system — how they create, deliver, or capture value.
Praram 9 Hospital Public Company Limited
Tier 1RuleThroughput-Bound ConversionFlowProduction
Surfilter Network Technology Co., Ltd.
Tier 1RuleThroughput-Bound ConversionSenseMakingProduction
Community Health Systems, Inc.
Tier 1RuleThroughput-Bound ConversionProductionFlow
Q & M Dental Group (Singapore) Ltd.
Tier 1RuleThroughput-Bound ConversionProductionFlow
Auna S.A.
Tier 1RuleThroughput-Bound ConversionRiskProduction
Liaoning He Eye Hospital Co., Ltd.
Tier 1RuleThroughput-Bound ConversionProductionFlow
Chengdu Bright Eye Hospital Co., Ltd.
Tier 1RuleThroughput-Bound ConversionProductionSenseMaking
Universal Vision Biotechnology Co., Ltd.
Tier 1RuleThroughput-Bound ConversionProductionInterface
Bangkok Chain Hospital Public Company Limited
Tier 1RuleThroughput-Bound ConversionProductionRisk
Ncs Testing Technology Co., Ltd.
Tier 1RuleThroughput-Bound ConversionSenseMakingProduction
Companies that share active interpretations — structural patterns currently present in both stocks.
FTAI Aviation Ltd.
4 interpretationsDepreciation-Heavy Reported ProfitEarnings Growth With Heavy Accrual ComponentElevated ROE With High Debt-to-Equity and Equity MultiplierROE, ROA, And Operating ROA Elevated
Groupe Dynamite Inc.
4 interpretationsOperating Income Growing With Multi-Year Revenue GrowthElevated ROE With High Debt-to-Equity and Equity MultiplierROE, ROA, And Operating ROA ElevatedThree Turnover Ratios Elevated
One Career Inc.
4 interpretationsWorking Capital PatternOperating Income Growing With Multi-Year Revenue GrowthROE, ROA, And Operating ROA ElevatedThree Turnover Ratios Elevated